Fresenius SE & Co. KGaA (FRE) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Fresenius SE & Co. KGaA (FRE) - Medical Equipment - Deals and Alliances Profile

Fresenius SE & Co. KGaA (FRE) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Fresenius SE & Co. KGaA (FRE) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
89 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Fresenius SE & Co. KGaA (Fresenius) is a global health care group, which offers products and services for dialysis treatment. It provides various dialysis services through its own clinics and sells its products to other dialysis service providers. Its major products and services includes machines for hemodialysis, acute dialysis and peritoneal dialysis; solutions for infusion therapy; dialysis care services; Spectra laboratories; liver support therapy services; and provision projects and services for hospitals and other health care facilities. It also operates and manages acute care and postacute care hospitals in Germany through Helios Kliniken Group.

Fresenius SE & Co. KGaA (FRE) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information

  
Source:
Document ID
GDME698D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents25
  List of Tables42
  List of Figures61
Fresenius SE &Co. KGaA, Medical Equipment, Deals By Year, 2010 to YTD 201662
Fresenius SE &Co. KGaA, Medical Equipment Deals By Type, 2010 to YTD 201681
Fresenius SE &Co. KGaA, Medical Equipment, Deals By Region, 2010 to YTD 201691
Fresenius SE &Co. KGaA, Medical Equipment, Deals By Market, 2010 to YTD 2016101
Fresenius SE &Co. KGaA, Medical Equipment, Deals Summary, 2010 to YTD 2016113
Fresenius SE &Co. KGaA, Medical Equipment, Deal Details1450
  Asset Purchase141
    Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson141
    Fresenius Medical Care Completes Acquisition Of International Dialysis Centers From Euromedic International152
    Fresenius Medical Care Acquires Crit-Line System Assets From Hema Metrics171
    Fresenius Medical Care Acquires Worldwide Peritoneal Dialysis Business From Gambro182
    Fresenius USA Completes Acquisition Of Assets Of Xcorporeal And National Quality Care202
    Fresenius Medical Care Canada Acquires Rights For NephroCare Software From Cybernius Medical221
    Fresenius Medical Care Acquires Dialysis Stations From Hand Prod231
  Partnerships241
    Fresenius Medical Care Extends Licensing Agreement with Interface Biologics241
    Debiotech and Fresenius Medical Care Enter into Agreement251
    Verax Biomedical Renews its Commercialization Agreement with Fresenius Kabi USA261
    Sequana Medical Enters into Distribution Agreement with Fresenius Medical Care271
    Toray Industries Enters into Distribution Agreement with Fresenius Medical Care281
    HemaTerra Technologies Enters Into Co-Development Agreement With Fenwal291
    Fenwal Enters Into Co-Marketing Agreement With Applied Science301
    JMS North America Enters Into Distribution Agreement With Fresenius Medical Care For AVF Needles311
    Fenwal Enters Into Co-Marketing Agreement With Biolog-id For RFID Blood Tracking System321
    Fenwal Enters Into Co-Marketing Agreement With Genesis BPS331
    Fenwal Signs An Agreement With AccuVein341
    Fresenius Medical Care Enters Into An Agreement With NIKKISO351
    ThermoGenesis Enters Into Distribution Agreement With Fenwal361
  Equity Offering371
    Fresenius Plans Private Placement Of Shares For US$1.3 Billion371
  Debt Offering381
    Fresenius Raises USD300 Million in Private Placement of Notes381
    Fresenius Medical Care Raises USD400 Million in Private Placement of 4.75% Notes Due 2024391
    Fresenius Medical Care Raises USD500 Million in Private Placement of 4.125% Notes Due 2020401
    Fresenius Medical Care Raises USD518 Million in Private Placement of Convertible Bonds411
    Fresenius Increases Size Of Private Placement Of Notes Due 2024 For US$611.4 Million421
    Fresenius Completes Private Placement Of Notes Due 2019 For US$407.6 Million431
    Fresenius Completes Private Placement Of Notes Due 2021 For US$611.4 Million441
    Fresenius Medical Care Prices Private Placement Of Notes Due 2020 For US$673 Million452
    Fresenius Medical Care Completes Private Placement Of 5.625% Senior Unsecured Notes Due 2019 For US$800 Million471
    Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2019 For US$316.4 Million481
    Fresenius Medical Care Completes Private Placement Of 5.875% Senior Unsecured Notes Due 2022 For US$700 Million491
    Fresenius Medical Care Completes Private Placement Of Floating-Rate Senior Notes Due 2016 For US$133.7 Million501
    Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For US$550 Million511
    Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For US$400 Million521
    Fresenius Medical Care Completes Private Placement Of 5.75% Senior Unsecured Notes Due 2021 For US$650 Million532
    Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2021 For US$403 Million551
    Fresenius Medical Care Completes Private Placement Of Senior Notes For US$360.42 Million561
  Asset Transactions571
    Fresenius Medical to Divest Dialysis Services Unit in Venezuela571
    Fresenius Medical Care Divests Fresenius Medical care Dialysis Clinic for USD1.4 Million581
  Acquisition591
    Fresenius Kabi Completes Acquisition Of Fenwal From TPG Capital And Maverick Capital For US$1.1 Billion592
    Fresenius Acquires 70% Stake In Huangshi Lishizhen Medicine Group Wuhan Xisu Pharma From Huangshi Lishizhen Medicine Group Wuhan Lishizhen Medicine611
    Fresenius Medical Care to Acquire Nefrocontrol621
    Fresenius Medical Care To Acquire Nikkiso Medical Korea From NIKKISO631
Fresenius SE &Co. KGaA - Key Competitors641
Key Employees651
Locations And Subsidiaries665
  Head Office661
  Other Locations &Subsidiaries665
Recent Developments711
Strategy And Business Planning711
Apr 08, 2016: Fresenius Vamed lays foundation stone for new university hospital building711
Financial Announcements721
Aug 01, 2016: Fresenius Medical Care posts accelerated earnings growth in the 2nd quarter723
May 03, 2016: Strong start into the year Double-digit earnings growth in constant currency Fresenius confirms Group guidance for 2016752
Feb 24, 2016: Outstanding 2015 financial results 25% dividend increase proposed Positive outlook for 2016 New mid-term growth targets774
Jul 29, 2015: Fresenius Medical Care Reports Second Quarter 2015 Results And Confirms Guidance For Full Year 2015812
Apr 29, 2015: Fresenius Medical Care reports first quarter 2015 results and confirms guidance for full year 2015831
Feb 25, 2015: Fresenius Medical Care reports fourth quarter and full year 2014 results843
Corporate Communications871
Jun 26, 2016: Fresenius appoints Stephan Sturm as new Chief Executive Officer Ulf Mark Schneider leaves the company to pursue another opportunity871
Other Significant Developments881
Aug 17, 2016: Fresenius Kabi investing nearly $250 million to expand plant near Chicago881
Appendix891
  Methodology891
  About GlobalData891
  Contact Us891
  Disclaimer891

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Fresenius SE & Co. KGaA (FRE) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Fresenius-SE-Co-KGaA-FRE-Medical-Equipment-Deals-and-Alliances-Profile-2148-1293>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Fresenius SE & Co. KGaA (FRE) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Fresenius-SE-Co-KGaA-FRE-Medical-Equipment-Deals-and-Alliances-Profile-2148-1293>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research